ATE283035T1 - Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen - Google Patents

Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen

Info

Publication number
ATE283035T1
ATE283035T1 AT99966144T AT99966144T ATE283035T1 AT E283035 T1 ATE283035 T1 AT E283035T1 AT 99966144 T AT99966144 T AT 99966144T AT 99966144 T AT99966144 T AT 99966144T AT E283035 T1 ATE283035 T1 AT E283035T1
Authority
AT
Austria
Prior art keywords
dna
proteins
methods
cochleate
transforming cells
Prior art date
Application number
AT99966144T
Other languages
English (en)
Inventor
David Margolis
Susan Gould-Fogerite
Raphael James Mannino
Original Assignee
Univ Maryland
Univ New Jersey Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland, Univ New Jersey Med filed Critical Univ Maryland
Application granted granted Critical
Publication of ATE283035T1 publication Critical patent/ATE283035T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
    • A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AT99966144T 1998-12-14 1999-12-13 Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen ATE283035T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/210,578 US6340591B1 (en) 1998-12-14 1998-12-14 Integrative protein-DNA cochleate formulations and methods for transforming cells
PCT/US1999/029446 WO2000035421A2 (en) 1998-12-14 1999-12-13 Integrative protein-dna cochleate formulations and methods for transforming cells

Publications (1)

Publication Number Publication Date
ATE283035T1 true ATE283035T1 (de) 2004-12-15

Family

ID=22783444

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99966144T ATE283035T1 (de) 1998-12-14 1999-12-13 Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen

Country Status (9)

Country Link
US (3) US6340591B1 (de)
EP (2) EP1140023B1 (de)
AT (1) ATE283035T1 (de)
AU (1) AU759178B2 (de)
CA (1) CA2354527A1 (de)
DE (1) DE69922248T2 (de)
ES (1) ES2233097T3 (de)
PT (1) PT1140023E (de)
WO (1) WO2000035421A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1237541B1 (de) * 1999-12-13 2004-09-01 Lipoxen Technologies Limited Liposomen enthaltend einen komplex aus polyanion und calciumphosphat
CN1674869A (zh) * 2002-08-06 2005-09-28 金拓 非金属阳离子作桥联剂的脂质卷
EP1624858B1 (de) 2003-04-09 2018-06-06 Rutgers, the State University of New Jersey Neue encochleationsverfahren
JP4789208B2 (ja) 2003-04-09 2011-10-12 バイオデリバリー サイエンシーズ インターナショナル インコーポレイティッド タンパク質発現に向けられた渦巻型組成物
US20060029656A1 (en) * 2004-02-03 2006-02-09 Biodelivery Sciences International, Inc. Replacement enzyme cochleates
EP1737427A2 (de) * 2004-04-09 2007-01-03 Biodelivery Sciences International, Inc. Nukleotid-cochleat-zusammensetzungen und anwendungsverfahren
US20100178325A1 (en) * 2006-08-23 2010-07-15 Biodelivery Sciences International, Inc. Amphiphilic nucleotide cochleate compositions and methods of using the same
TW200833709A (en) 2006-12-15 2008-08-16 Ca Nat Research Council Archaeal polar lipid aggregates for administration to animals
US20220226465A1 (en) 2021-01-18 2022-07-21 ConserV Bioscience Coronavirus Immunogenic Compositions, Methods and Uses Thereof
WO2024038407A1 (en) * 2022-08-19 2024-02-22 Seqirus Inc. Lipid nanoparticle comprising a dna-binding protein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993024640A2 (en) * 1992-06-04 1993-12-09 The Regents Of The University Of California Methods and compositions for in vivo gene therapy
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US5840707A (en) 1993-10-04 1998-11-24 Albany Medical College Stabilizing and delivery means of biological molecules
US6342390B1 (en) 1994-11-23 2002-01-29 The United States Of America As Represented By The Secretary Of Health And Human Services Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy
US5843742A (en) 1994-12-16 1998-12-01 Avigen Incorporated Adeno-associated derived vector systems for gene delivery and integration into target cells
US5972899A (en) * 1996-01-25 1999-10-26 New York University Apoptosis induced by Shigella IpaB
CA2246754C (en) 1996-02-22 2002-10-22 Raphael James Mannino Cochleate delivery vehicles

Also Published As

Publication number Publication date
DE69922248T2 (de) 2005-11-03
CA2354527A1 (en) 2000-06-22
EP1525881A2 (de) 2005-04-27
AU2175600A (en) 2000-07-03
ES2233097T3 (es) 2005-06-01
WO2000035421A3 (en) 2000-11-09
US20050129661A1 (en) 2005-06-16
DE69922248D1 (de) 2004-12-30
WO2000035421A2 (en) 2000-06-22
PT1140023E (pt) 2005-03-31
AU759178B2 (en) 2003-04-10
US6340591B1 (en) 2002-01-22
US20020034822A1 (en) 2002-03-21
EP1140023B1 (de) 2004-11-24
EP1140023A2 (de) 2001-10-10

Similar Documents

Publication Publication Date Title
HUP9700428A2 (hu) Célsejtspecifikus vektorok gének beépítésére, a vektorokat tartalmazó gyógyászati készítmények és azok alkalmazása
WO2000027994A3 (en) Chlamydia pneumoniae genome sequence
NO962791D0 (no) Preparater inneholdende nukleinsyrer, deres fremstilling og anvendelse
WO2004063362A3 (en) Cell cycle progression proteins
DK0973928T3 (da) DNA-baseret transposonsystem til indføring af nukleinsyre i DNA i en celle
DE69906977D1 (de) In liposomen verkapselte nukleinsäurekomplexe
ATE503843T1 (de) Gesamt-chromosom analyse von protein-dns wechselwirkungen
AUPN477695A0 (en) Gene therapy
NO973838L (no) DNA-molekyler, deres fremstilling samt anvendelse ved genterapi
CY1115405T1 (el) Αλληλουχιες κυκλοϊου που συνδyαζονται με την ασθενεια της καχεξιας του χοιριδιου (map)
WO2000052155A3 (en) Recombination of insertion modified nucleic acids
DE60328383D1 (de) Zusammensetzungen zur zuführung von nukleinsäuren an zellen
DE69922248D1 (de) Integriertende protein-dna cochleateformulierungen und verfahren zur transformation von zellen
DE69819124D1 (de) Lyophilisation von kultivierten, menschlichen zellen zur konservierung der rna und dna
HUP9800329A2 (hu) Nukleinsavkonstrukciók strukturális gének sejtciklus-függő módon szabályozott expresszálására
WO2000053776A3 (en) Human kallikrein-like genes
DK1144600T3 (da) Akt-3-nukleinsyre, polypeptider og anvendelser deraf
DK1082423T3 (da) Cyclin E2-gener og -proteiner
ATE384263T1 (de) Verfahren zur bestimmung von biologischen agenzien in lebenden zielzellen
WO2000008157A3 (en) Human anion transporter genes atnov
DK0843731T3 (da) Adenovirusvektorer til genterapi
ATE288488T1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
GB2322132B (en) Keratinocyte growth factor-2 products
WO2002032939A3 (en) Secreted proteins and their uses
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140023

Country of ref document: EP

REN Ceased due to non-payment of the annual fee